GT Biopharma files 8-K to announce updated corporate presentation on website; no specifics disclosed

GT Biopharma, Inc.

Filing states corporate presentation as of Nov 1, 2021 was posted to company website.
Presentation filed as Exhibit 99.1 but full content not provided in filing text.
No financial results, guidance, or operational changes mentioned in the filing.
Ticker: GTBP; common stock listed on Nasdaq.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.